Can constipation contribute to urinary incontinence?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Yes, Constipation Can Contribute to Urinary Incontinence

Constipation is a recognized risk factor for urinary incontinence in women and should be actively assessed and treated as part of UI management. The American College of Physicians explicitly identifies constipation as a risk factor for urinary incontinence 1, and this relationship is supported by substantial research evidence.

The Evidence for This Association

Guideline Recognition

The ACP clinical practice guideline on nonsurgical management of urinary incontinence clearly lists constipation among the established risk factors for UI, alongside pregnancy, pelvic floor trauma, menopause, obesity, and urinary tract infections 1. This recognition in a major clinical guideline from 2014 establishes constipation as a clinically relevant contributor that should not be overlooked.

Research Support

The association is further validated by recent high-quality research:

  • A 2024 cross-sectional analysis of NHANES data involving 4,686 adults found that constipation significantly increased the risk of both urgency UI (OR 1.42,95% CI 1.11-1.83) and stress UI (OR 1.32,95% CI 1.06-1.63) 2. This large population-based study provides robust evidence for the relationship.

  • A 2019 meta-analysis of 16 observational studies with 35,629 participants demonstrated that constipation was significantly associated with UI risk in women (OR 2.46,95% CI 1.79-3.38) 3. This pooled analysis represents the strongest available evidence for the magnitude of association.

  • A 2022 cohort study of 875 women with chronic constipation found they were more likely to experience urogenital symptoms including urinary hesitancy and incomplete bladder emptying, with symptom severity correlating with constipation severity 4.

Mechanisms Explaining the Connection

The anatomical and functional relationship between the bowel and bladder explains this association 5:

  • Direct mechanical compression: A distended rectum filled with stool can compress the bladder and urethra, affecting bladder capacity and urethral function
  • Pelvic floor dysfunction: Chronic straining from constipation can weaken pelvic floor muscles that support both bowel and bladder control
  • Shared neural pathways: The bowel and bladder share common nerve pathways, so dysfunction in one system affects the other

Clinical Implications for Practice

Assessment

When evaluating any patient with urinary incontinence, specifically ask about:

  • Bowel movement frequency (less than 3 per week suggests constipation)
  • Stool consistency and straining
  • Sensation of incomplete evacuation
  • Use of laxatives or manual maneuvers

Treatment Approach

Addressing constipation should be part of the initial management strategy for UI, not an afterthought. The evidence from pediatric populations is particularly compelling: treating constipation resulted in resolution of daytime UI in 89% and nighttime UI in 63% of children 6. While adult data is less dramatic, the principle holds.

For constipation management in the context of UI:

  • Gradual increase in dietary fiber to 25-30 g daily 7
  • Adequate fluid intake, particularly water rich in magnesium
  • Regular toileting habits
  • Osmotic laxatives (polyethylene glycol, lactulose) or stimulant laxatives (senna, bisacodyl) as needed 8

Important Caveats

  • The relationship appears bidirectional and complex—both conditions share common risk factors like obesity, reduced mobility, and medications
  • Treating constipation alone may not fully resolve UI, but failing to address it will reduce treatment success rates 5
  • In cancer patients, constipation can lead to urinary retention as a complication 8, highlighting the importance of prevention

Bottom Line for Clinical Practice

Screen all UI patients for constipation and treat it concurrently with UI-specific therapies. The evidence consistently shows that constipation worsens UI symptoms and that addressing bowel dysfunction improves urinary outcomes. This is particularly critical in elderly patients, who have higher rates of both conditions 8. The failure to detect and treat constipation will substantially reduce your success rate in managing urinary incontinence 5.

References

3
Research

Constipation and risk of urinary incontinence in women: a meta-analysis.

International urogynecology journal, 2019

5
Research

The impact of constipation on the urinary tract system.

International journal of adolescent medicine and health, 2008

Related Questions

How should a 3.5-year-old boy with penile swelling, acute urinary retention, constipation, fever, and a history of recurrent infections since age 2 and prior pneumonia be managed?
How should I evaluate and manage a 3‑year‑old boy with chronic daytime urinary frequency, nighttime enuresis requiring multiple diaper changes, intermittent constipation (bowel movements every 2–3 days), no history of urinary tract infection, and normal growth?
How does constipation affect urinary retention?
Is it normal to experience difficulty urinating after an episode of diarrhea?
What could cause concurrent diarrhea and urinary retention?
In a 53‑year‑old, 37‑kg woman with type 2 diabetes, insulin resistance, and a high‑carbohydrate diet, currently using insulin glargine (Lantus) 24 units daily, an insulin‑to‑carbohydrate ratio of 6 g per unit, and an insulin‑sensitivity factor of 25 mg/dL per unit, what should her insulin‑sensitivity factor, insulin‑to‑carbohydrate ratio, and basal insulin dose be adjusted to?
What is the optimal diuretic and fluid‑restriction plan to achieve approximately 5 kg weight loss before hip arthroplasty scheduled in 20 days for a patient on furosemide 40 mg daily, hydrochlorothiazide 25 mg daily, with normal labs and blood pressure, and taking methadone 10 mg for pain control?
What is the appropriate dose of metoprolol for rate control in atrial fibrillation during pregnancy?
What is the definition of a widened mediastinum on chest radiograph and how should it be evaluated and managed?
What is the recommended high-level disinfection protocol for colonoscopes used on HIV-positive patients?
What are the ESMO guidelines for the clinical and diagnostic approach to febrile neutropenia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.